Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017

In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Priya Rathi, Kalpita Shringarpure, Bhaskaran Unnikrishnan, Vineet Kumar Chadha, Vishak Acharya, Abirami Nair, Karuna D. Sagili, Suresh Shastri
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Centers for Disease Control and Prevention 2020-05-01
Edice:	Emerging Infectious Diseases
Témata:	Multidrug-resistant tuberculosis MDR TB tuberculosis and other mycobacteria presumptive MDR TB direct cost indirect cost
On-line přístup:	https://wwwnc.cdc.gov/eid/article/26/5/18-1992_article
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!